Literature DB >> 30277092

Most multiple myeloma patients have low testosterone.

Sonya John1, Nidhi Sharma2, Douglas W Sborov3, Nita Williams2, Desirée Jones2, Don M Benson2, Yvonne A Efebera2, Ashley E Rosko2, Jennifer Vincent2, Craig C Hofmeister2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30277092      PMCID： PMC6445785          DOI： 10.1080/10428194.2018.1508664

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  15 in total

1.  Testosterone levels and quality of life in diverse male patients with cancers unrelated to androgens.

Authors:  Stewart B Fleishman; Hina Khan; Peter Homel; Mohammad F Suhail; Rotraud Strebel-Amrhein; Farhan Mohammad; Divya Mahajan; Victoria Rosenwald; Michael J Guarino; Tahir Mirzoyev; Timothy F Wozniak; Kathiresan Suppiah
Journal:  J Clin Oncol       Date:  2010-10-25       Impact factor: 44.544

2.  Thalidomide-associated gynecomasty in a patient with multiple myeloma.

Authors:  Marc Pulik; Philippe Genet; François Lionnet; Tahar Touahri
Journal:  Am J Hematol       Date:  2002-07       Impact factor: 10.047

Review 3.  Clinical review 24: Androgens in the aging male.

Authors:  A Vermeulen
Journal:  J Clin Endocrinol Metab       Date:  1991-08       Impact factor: 5.958

4.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

5.  Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men.

Authors:  J A Osuna; R Gómez-Pérez; G Arata-Bellabarba; V Villaroel
Journal:  Arch Androl       Date:  2006 Sep-Oct

6.  Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men.

Authors:  Onder Canguven; Raidh A Talib; Walid El Ansari; Dany-Jan Yassin; Abdullah Al Naimi
Journal:  Aging Male       Date:  2017-01-11       Impact factor: 5.892

7.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe Casanueva; Gianni Forti; Aleksander Giwercman; Ilpo T Huhtaniemi; Krzysztof Kula; Margus Punab; Steven Boonen; Dirk Vanderschueren
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

8.  Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation.

Authors:  Xin Shelley Wang; Qiuling Shi; Nina D Shah; Cobi J Heijnen; Evan N Cohen; James M Reuben; Robert Z Orlowski; Muzaffar H Qazilbash; Valen E Johnson; Loretta A Williams; Tito R Mendoza; Charles S Cleeland
Journal:  Clin Cancer Res       Date:  2014-01-14       Impact factor: 12.531

9.  Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study.

Authors:  Gideon Sartorius; Sasa Spasevska; Amanda Idan; Leo Turner; Elise Forbes; Anna Zamojska; Carolyn A Allan; Lam P Ly; Ann J Conway; Robert I McLachlan; David J Handelsman
Journal:  Clin Endocrinol (Oxf)       Date:  2012-11       Impact factor: 3.478

10.  Gynaecomastia complicating the treatment of myeloma.

Authors:  D M Large; J M Jones; S M Shalet; J H Scarffe; A C Gibbs
Journal:  Br J Cancer       Date:  1983-07       Impact factor: 7.640
View more
  1 in total

Review 1.  A comprehensive review of the impact of obesity on plasma cell disorders.

Authors:  Richa Parikh; Syed Maaz Tariq; Catherine R Marinac; Urvi A Shah
Journal:  Leukemia       Date:  2021-10-15       Impact factor: 12.883
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.